Principal Financial Group Inc. raised its stake in Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report) by 1,590.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 485,433 shares of the company’s stock after acquiring an additional 456,715 shares during the quarter. Principal Financial Group Inc.’s holdings in Clover Health Investments were worth $1,485,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently modified their holdings of the stock. Geode Capital Management LLC lifted its stake in Clover Health Investments by 95.7% in the second quarter. Geode Capital Management LLC now owns 9,843,349 shares of the company’s stock valued at $27,467,000 after purchasing an additional 4,812,368 shares during the last quarter. Bank of America Corp DE grew its stake in shares of Clover Health Investments by 217.5% during the 2nd quarter. Bank of America Corp DE now owns 4,012,744 shares of the company’s stock worth $11,196,000 after acquiring an additional 2,748,783 shares during the period. First Trust Advisors LP purchased a new stake in Clover Health Investments in the 2nd quarter worth about $4,149,000. Connor Clark & Lunn Investment Management Ltd. raised its stake in Clover Health Investments by 11.2% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 954,848 shares of the company’s stock valued at $2,664,000 after acquiring an additional 95,811 shares during the period. Finally, Jupiter Asset Management Ltd. raised its stake in Clover Health Investments by 575.9% in the 2nd quarter. Jupiter Asset Management Ltd. now owns 939,590 shares of the company’s stock valued at $2,621,000 after acquiring an additional 800,581 shares during the period. Hedge funds and other institutional investors own 19.77% of the company’s stock.
Clover Health Investments Price Performance
CLOV opened at $2.04 on Wednesday. The firm has a market capitalization of $1.05 billion, a P/E ratio of -18.55 and a beta of 2.09. Clover Health Investments, Corp. has a one year low of $2.01 and a one year high of $4.80. The company has a fifty day moving average price of $2.43 and a 200-day moving average price of $2.66.
Analyst Ratings Changes
Get Our Latest Stock Analysis on CLOV
About Clover Health Investments
Clover Health Investments is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members.
At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams.
See Also
- Five stocks we like better than Clover Health Investments
- Energy Security Is Now National Security – Positioning Is Happening Now
- The “Bomb” in America’s Basement
- The gold chart Wall Street is terrified of…
- Unlocked: Elon Musk’s Next Big IPO
- How to collect $1,170 a month from silver
Want to see what other hedge funds are holding CLOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report).
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.
